[The role of rFVIIa in treatment of severe postpartum haemorrhage: to evaluate the risk/benefit ratio].
Aya
A-G
AG
Mercier
F-J
FJ
D005069:Evaluation Studies as Topic; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006473:Postpartum Hemorrhage / Q000188:drug therapy*; D011247:Pregnancy; D011994:Recombinant Proteins / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index
D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa